McKesson to pay $150M to settle suspicious order practices lawsuit

San Francisco-based McKesson has agreed to settle claims with the Department of Justice, Drug Enforcement Administration and various U.S. Attorney’s offices alleging suspicious order reporting practices for controlled substances by paying $150 million and suspending at least three distribution center registrations for two years, according to Reuters.

Advertisement

McKesson has suspended the DEA registrations for specific products at its Aurora, Colo., Livonia, Mich., Washington Courthouse, Ohio, and Lakeland, Fla., distribution warehouses for between one and three years, according to McKesson’s 8-K filing with the SEC.

The company’s Landover, Md., distribution center is also being investigated, according to Reuters.

More articles on health IT:

Senators form working group to address EHR usability
10 most-read health IT stories in April
Teladoc to file for IPO: 5 things to know

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Health IT

Advertisement

Comments are closed.